Published in J Urol on February 26, 2013
Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production. Neurobiol Aging (2013) 0.90
Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine. Oncotarget (2014) 0.83
Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update. EXCLI J (2014) 0.81
Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer. Dis Markers (2015) 0.80
Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature. Diagn Pathol (2014) 0.79
Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies. BBA Clin (2015) 0.77
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases. Exp Biol Med (Maywood) (2016) 0.75
Non-blood circulating tumor DNA detection in cancer. Oncotarget (2017) 0.75
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res (2003) 1.46
Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem (2011) 1.45
The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J Biol Chem (2009) 1.35
Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med (2010) 1.34
miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am J Pathol (2012) 1.34
Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics (2009) 1.24
Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. J Proteome Res (2007) 1.03
Galectin-3 expression is associated with bladder cancer progression and clinical outcome. Tumour Biol (2010) 1.01
Differential protein expression profiling by iTRAQ-two-dimensional LC-MS/MS of human bladder cancer EJ138 cells transfected with the metastasis suppressor KiSS-1 gene. Mol Cell Proteomics (2010) 0.96
KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer. Tumour Biol (2012) 0.91
Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med (2010) 0.91
Multiplexed methylation profiles of tumor suppressor genes in bladder cancer. J Mol Diagn (2010) 0.91
Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer. Tumour Biol (2012) 0.90
KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients. Am J Pathol (2011) 0.89
Identification of PMF1 methylation in association with bladder cancer progression. Clin Cancer Res (2008) 0.88
Urine epigenomics: a promising path for bladder cancer diagnostics. Expert Rev Mol Diagn (2012) 0.87
Postpartum amaurosis in a woman with severe preeclampsia. Indian J Crit Care Med (2011) 0.87
Myopodin methylation is associated with clinical outcome in patients with T1G3 bladder cancer. J Urol (2010) 0.86
Myocilin and optineurin coding variants in Hispanics of Mexican descent with POAG. J Hum Genet (2010) 0.85
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA. J Transl Med (2013) 0.83
A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells. Am J Pathol (2013) 0.82
A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness. PLoS One (2013) 0.82
Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome. Heart Rhythm (2010) 0.80
Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors. Tumour Biol (2014) 0.80
Polyamine-modulated factor-1 methylation predicts Bacillus Calmette-Guérin response in patients with high-grade non-muscle-invasive bladder carcinoma. Eur Urol (2012) 0.79
Humoral immune response in hens naturally infected with Salmonella Enteritidis against outer membrane proteins and other surface structural antigens. Vet Res (2004) 0.77
[Concealed channelopathy in a patient with recurrent ventricular fibrillation treated with catheter ablation]. Rev Esp Cardiol (2011) 0.76
Spanish implantable cardioverter-defibrillator registry. 5th official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2008). Rev Esp Cardiol (2009) 0.76
Five years of catheter ablation procedures in South-Western Europe: meta-analysis of National Registries. Pacing Clin Electrophysiol (2009) 0.75
[Vasovagal syncope in pediatric patients: a medium-term follow-up analysis]. Rev Esp Cardiol (2002) 0.75
Juvenile xanthogranuloma of skull base. Case report and review of the literature. Acta Neurochir (Wien) (2013) 0.75
[Left ventricular dysfunction induced by monomorphic ventricular arrhythmias: large improvement in ventricular function after radiofrequency ablation of the arrhythmic source]. Rev Esp Cardiol (2005) 0.75
[Spanish registry of implantable cardioverter defibrillator. Second official report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter Defibrillators (2005)]. Rev Esp Cardiol (2006) 0.75
Questionnaire of executive function for dancers: an ecological approach. Assessment (2011) 0.75
[Spanish implantable cardioverter-defibrillator registry. First official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2002-2004)]. Rev Esp Cardiol (2005) 0.75
Ureteral inverted papilloma: laparoscopic distal ureterectomy and boari flap. Arch Esp Urol (2012) 0.75
[Spanish Implantable Cardioverter-Defibrillator Registry. Fourth Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2007)]. Rev Esp Cardiol (2008) 0.75
[Spanish Implantable Cardioverter-Defibrillator Registry. Third Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2006)]. Rev Esp Cardiol (2007) 0.75